NovelStem International Corp. (NSTM)

Overview

NovelStem International Corp., originally known as Hollywood Media Corp., is a developmental stage biotechnology holding company that was rebranded in September 2018. With its foundation laid in 1993, the company is strategically located in Boca Raton, Florida, positioning itself at the forefront of biotechnological innovation. At its core, NovelStem International Corp. is dedicated to the discovery, development, and commercialization of pioneering stem cell-based diagnostic technologies. Primarily, it seeks to revolutionize cancer treatments and address the critical challenge of reducing resistance to chemotherapy, a significant hurdle in the treatment of cancer. Transitioning from its previous identity, NovelStem has shifted its focus towards leveraging cutting-edge biotechnological advancements to contribute to the oncological field, thereby embodying its commitment to enhancing patient care and outcomes through innovative solutions.

Products and Services

• Stem Cell-Based Diagnostic Technology

  This cutting-edge technology is the cornerstone of NovelStem International Corp.’s offerings. It is designed to facilitate early diagnosis and personalized treatment plans for cancer patients. By utilizing stem cells, the company aims to develop diagnostics that can accurately identify cancerous cells and determine their susceptibility to various chemotherapy regimens. This approach not only aims to improve the efficacy of cancer treatments but also significantly reduce the occurrence of resistance to chemotherapy, a prevalent challenge in oncology.